Intellia Therapeutics

Intellia Therapeutics, Inc. is a biotechnology company specializing in the development of gene-editing therapies using CRISPR/Cas9 technology. They focus on creating treatments for genetic diseases by precisely altering DNA within patients' cells. Founded in 2014, Intellia has made significant strides in advancing CRISPR-based therapies and has multiple programs in clinical and preclinical stages. The company generates revenue through collaborations, licensing agreements, and research grants, aiming to bring transformative treatments to market.

Recent Posts by Intellia Therapeutics

1-20 of 163